Yıl: 2022 Cilt: 44 Sayı: 4 Sayfa Aralığı: 580 - 586 Metin Dili: İngilizce DOI: 10.20515/otd.978880 İndeks Tarihi: 07-09-2022

Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.

Öz:
Multiple sclerosis (MS) and anti-phospholipid syndrome (APS) are chronic, immune-mediated, relapsing-remitting disorders affecting young adults. APS is characterized by thrombosis and pregnancy mortality associated with anti-phospholipid antibodies. The diagnosis of APS may be difficult, and it is not uncommon for patients with APS to be misdiagnosed with multiple sclerosis. In this case report, we describe a patient who was diagnosed as having multiple sclerosis for eleven-year. Initially, the patient had neurological deficits with relapsing-remitting courses, like MS but he had not classic magnetic resonance imaging appearance of MS and absence of oligoclonal bands in the cerebrospinal fluid. He did not meet the 'dissemination criteria in time and place' specified in the MS diagnostic criteria. Also, he had an acute myocardial infarction and ischemic stroke at different times. The diagnosis of primary APS was made after the patient had thrombotic attacks, seizure and was positive for anti-phospholipid antibodies (aPLs) twice. Our observations raise awareness about the importance of the early and correct diagnosis of APS. When assessing MS patients, clinicians should consider APS, if the MS has atypical features.
Anahtar Kelime: Multiple sclerosis Anti-phospholipid syndrome misdiagnose multiple sclerosis-like syndrome.

Multipl Skleroz Olarak Yanlış Teşhis Edilen Antifosfolipid Sendromu: Bir Olgu Sunumu.

Öz:
Multipl skleroz ve anti-fosfolipid sendromu (AFAS), genç yetişkinleri etkileyen kronik, immün aracılı, relapsing-remitting bozukluklardır. AFAS, anti-fosfolipid antikorları ile ilişkili tromboz ve gebelik mortalitesi ile karakterizedir. AFAS tanısı zor olabilir ve AFAS’lı hastaların yanlış multipl skleroz tanısı alması nadir değildir. Bu olgu sunumunda, on bir yıldır multipl skleroz tanısı ile izlenen bir hastayı tanımladık. Başlangıçta hastanın MS benzeri relapsing- remitting seyirli nörolojik defisitleri vardı ancak MS'in klasik manyetik rezonans görüntüleme görünümü ve beyin omurilik sıvısında oligoklonal bantlar yoktu. Hasta MS tanı kriterlerinde belirtilen ‘zamanda ve mekanda yayılım kriterleri’ ni karşılamıyordu. Ayrıca farklı zamanlarda akut miyokard infarktüsü ve iskemik inme geçirmişti. Primer AFAS tanısı, hastanın iskemik serebral inme geçirmesi, nöbet ve iki kez aPL pozitif olması üzerine konuldu. Gözlemlerimiz, AFAS’ın erken ve doğru teşhisinin önemi konusunda farkındalık yaratmaktadır. MS hastalarını değerlendirirken, klinisyenler MS'nin atipik özellikleri varsa AFAS’ı düşünmelidir.
Anahtar Kelime: Multipl skleroz Antifosfolipid sendrom yanlış tanı multipl skleroz benzeri sendrom

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Myakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
  • 2. Laura Durcan and Michelle Petri. Epidemiology of the Antiphospholipid Syndrome Chapter 2. Handbook of Systemic Autoimmune Diseases. 2017;12:17-30.
  • 3. Yoav Arnson, Yehuda Shoenfeld, Eisen Alon and Howard Amita. Antiphosholipid syndrome as neurological disease. Semin Arthritis Rheum. 2010; 40:97-108.
  • 4. Andrew J, Solomon, Brain G. Weinshenker. Misdiagnosis of multiple sclerosis: Frequency, Causes, Effects, and Prevention. Curr. Neurol neurosci Rep. 2013; 13:403.
  • 5. Cervera R, Piette JC, Front J, et al. Antiphospkolipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1.000 patients. Arthritis rheum. 2002;46:1019-27.
  • 6. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology. 2003;42:200-13.
  • 7. Lockshin M, Tenedios F, Petri M, et al. Cardiac disease in the antiphospholipid syndrome:recommendations for treatment. Committee consensus report. Lupus. 2003;12:518-23.
  • 8. Guillermo RI, Crowther M, Branch W, et al. Anti-phospholipid syndrome. Lancet. 2010;376:1498-1509.
  • 9. Hughes GR. Thrombosis,abortion,cerebral disease,and the lupus anticoagulant. Br Med J (Clin Res Ed). 1983; 287: 1088–89.
  • 10. Sanna G, D’Cruz D,Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am. 2006; 32: 465–90.
  • 11. Yelnik CM, Kozora E, Appenzeller S. Non- stroke central neurologic manifestations in antiphospholipid syndrome. Curr Rheumatol Rep. 2016; 18:
  • 12. Rodrigues CEM, Carvalho JF, Shoenfeld Y. Neurological manifestations of anti- phospholipid syndrome. Eur J Clin Invest. 2010; 40 350–59.
  • 13. Gris JC, Nobile B, Bouvier S. Neuropsychiatric presentations of antiphospholipid antibodies. Thromb Res. 2015; 135 (Suppl 1): S56–S59.
  • 14. Fernandez-Fernandez FJ,Rivera-Gallego A,de la Fuente-Aguado J, et al. Antiphospholipid syndrome mimicking multiple sclerosis in two patients. Eur J Intern Med. 2006; 17: 500–502.
  • 15. Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore). 2000; 79: 57–68.
  • 16. Zhu DS, Fu J, Zhang Y, Li SX, Zhang GX, Guan YT, Dong Q. Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics. J Neurol Sci. 2014;346:138-44.
  • 17. Keiserman B, da Silva LF, Keiserman MW, et al. Lupoid sclerosis. Rheumatol Int. 2010;30:431–4.
  • 18. Heinzlef O, Weill B, Johanet C, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry. 2002; 72: 647–49.
  • 19. Liedorp M, Sanchez E, van Hoogstraten IMW, et al. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardio- lipin antibody testing based on magnetic resonance imaging and long term follow-up. J Neurol Neurosurg Psychiatry. 2007; 78: 1146–48.
  • 20. Bidot CJ, Horstman LL, Jy W, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: A preliminary study. BMC Neurol. 2007; 7: 36.
  • 21. Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, et al. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus. 2012; 21: 412–20.
  • 22. Karussis D, Leker RR, Ashkenazi A, et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity? Ann Neurol. 1998; 44: 629–34.
  • 23. Baraczka K, Lakos G, Sipka S. Immunoserological changes in the cerebro- spinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sc lerosis. Acta Neurol Scand. 2002; 105: 378–83.
  • 24. Roussel V, Yi F, Jauberteau MO, et al. Prevalence and clinical significance of anti- phospholipid antibodies in multiple sclerosis: A study of 89 patients. J Autoimmun. 2000; 14: 259–65.
  • 25. Garg N, Zivadinov R, Ramanathan M, et al. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol. 2007; 187: 159–65.
  • 26. Siva A. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. Neurol Clin. 2018 Feb;36:69-117.
  • 27. Thompson AJ et al. Diagnosis of multiple sclerosis: 2017 revisions of the Mc Donald criteria. The Lancet Neurology. Feb 2018 ; Vol: 17, Issue 2: 162-173.
  • 28. Maria J Cuadrado, Munther A. Khamashta, Angel Ballesteros, et al. Can Neurologic manifestations of Hughes (Antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literatüre. Medicine. 2000;1:57-68.
APA TEKGÖL UZUNER G, Özdemir A, korkmaz c, Uzuner N (2022). Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. , 580 - 586. 10.20515/otd.978880
Chicago TEKGÖL UZUNER GÜLNUR,Özdemir Atilla Özcan,korkmaz cengiz,Uzuner Nevzat Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. (2022): 580 - 586. 10.20515/otd.978880
MLA TEKGÖL UZUNER GÜLNUR,Özdemir Atilla Özcan,korkmaz cengiz,Uzuner Nevzat Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. , 2022, ss.580 - 586. 10.20515/otd.978880
AMA TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. . 2022; 580 - 586. 10.20515/otd.978880
Vancouver TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. . 2022; 580 - 586. 10.20515/otd.978880
IEEE TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N "Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.." , ss.580 - 586, 2022. 10.20515/otd.978880
ISNAD TEKGÖL UZUNER, GÜLNUR vd. "Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.". (2022), 580-586. https://doi.org/10.20515/otd.978880
APA TEKGÖL UZUNER G, Özdemir A, korkmaz c, Uzuner N (2022). Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. Osmangazi Tıp Dergisi, 44(4), 580 - 586. 10.20515/otd.978880
Chicago TEKGÖL UZUNER GÜLNUR,Özdemir Atilla Özcan,korkmaz cengiz,Uzuner Nevzat Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. Osmangazi Tıp Dergisi 44, no.4 (2022): 580 - 586. 10.20515/otd.978880
MLA TEKGÖL UZUNER GÜLNUR,Özdemir Atilla Özcan,korkmaz cengiz,Uzuner Nevzat Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. Osmangazi Tıp Dergisi, vol.44, no.4, 2022, ss.580 - 586. 10.20515/otd.978880
AMA TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. Osmangazi Tıp Dergisi. 2022; 44(4): 580 - 586. 10.20515/otd.978880
Vancouver TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.. Osmangazi Tıp Dergisi. 2022; 44(4): 580 - 586. 10.20515/otd.978880
IEEE TEKGÖL UZUNER G,Özdemir A,korkmaz c,Uzuner N "Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.." Osmangazi Tıp Dergisi, 44, ss.580 - 586, 2022. 10.20515/otd.978880
ISNAD TEKGÖL UZUNER, GÜLNUR vd. "Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report.". Osmangazi Tıp Dergisi 44/4 (2022), 580-586. https://doi.org/10.20515/otd.978880